IM Cannabis (IMCC) Other Working Capital Changes (2024 - 2025)
IM Cannabis (IMCC) recorded quarterly Other Working Capital Changes of $1.8 million in Q4 2025, up 1349.35% quarter-over-quarter from -$143147.1 in Q3 2025, and down 46.58% on a YoY basis from $3.3 million in Q4 2024.
IM Cannabis (IMCC) Other Working Capital Changes (2024 - 2025) Analysis & Trends
IM Cannabis' Other Working Capital Changes history runs 2 years deep, the most recent figure standing at $1.8 million for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 46.58% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $3.1 million (changed N/A YoY), while the FY2024 annual figure was $1.4 million, up 44.29% from the prior year.
- Other Working Capital Changes was $1.8 million for Q4 2025 at IM Cannabis, up from -$143147.1 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.3 million in Q4 2024 to a low of -$1.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.79 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | -143,147.10 |
| Sep 30, 2025 | -143,147.10 |
| Dec 31, 2024 | 3.35 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.85 Mn |